205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.99%
Revenue growth at 50-75% of ADI's 8.58%. Martin Whitman would worry about competitiveness or product relevance.
10.72%
Gross profit growth similar to ADI's 11.11%. Walter Schloss would assume both firms track common industry trends.
8.22%
EBIT growth below 50% of ADI's 30.43%. Michael Burry would suspect deeper competitive or cost structure issues.
8.22%
Operating income growth under 50% of ADI's 30.43%. Michael Burry would be concerned about deeper cost or sales issues.
-28.46%
Negative net income growth while ADI stands at 32.73%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-4.55%
Negative EPS growth while ADI is at 29.17%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
-33.13%
Share reduction while ADI is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-34.35%
Reduced diluted shares while ADI is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
53.69%
Dividend growth of 53.69% while ADI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-63.17%
Negative OCF growth while ADI is at 83.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-101.01%
Negative FCF growth while ADI is at 90.55%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
0.94%
10Y revenue/share CAGR under 50% of ADI's 174.48%. Michael Burry would suspect a lasting competitive disadvantage.
32.83%
5Y revenue/share CAGR at 50-75% of ADI's 61.89%. Martin Whitman would worry about a lagging mid-term growth trajectory.
18.57%
Positive 3Y CAGR while ADI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-19.88%
Negative 10Y OCF/share CAGR while ADI stands at 638.84%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
67.07%
Below 50% of ADI's 163.73%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
237.16%
Positive 3Y OCF/share CAGR while ADI is negative. John Neff might see a big short-term edge in operational efficiency.
130.60%
Below 50% of ADI's 527.08%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
32.77%
Below 50% of ADI's 214.04%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
62.90%
Positive short-term CAGR while ADI is negative. John Neff would see a clear advantage in near-term profit trajectory.
309.80%
10Y equity/share CAGR at 50-75% of ADI's 528.20%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
66.92%
Below 50% of ADI's 136.92%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-5.11%
Negative 3Y equity/share growth while ADI is at 29.92%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
83.26%
Dividend/share CAGR of 83.26% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
3.43%
Dividend/share CAGR of 3.43% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
2.09%
3Y dividend/share CAGR of 2.09% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
15.64%
AR growth well above ADI's 7.16%. Michael Burry fears inflated revenue or higher default risk in the near future.
16.67%
Inventory growth well above ADI's 1.78%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
1.77%
Asset growth well under 50% of ADI's 5.12%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
52.33%
BV/share growth above 1.5x ADI's 4.56%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-0.36%
We’re deleveraging while ADI stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
10.27%
R&D growth drastically higher vs. ADI's 4.83%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
14.94%
SG&A growth well above ADI's 5.64%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.